NanoRepro AG (NN6.DE) XETRA

1.53

-0.025(-1.61%)

Updated at December 05 10:57AM

Currency In EUR

NanoRepro AG

Address

Untergasse 8

Marburg, 35037

Germany

Phone

49 6421 951449

Sector

Healthcare

Industry

Medical - Diagnostics & Research

Employees

22

First IPO Date

October 22, 2009

Key Executives

NameTitlePayYear Born
Ms. Lisa JungstPresident of the Management Board & Chief Executive Officer0N/A
Mr. Stefan PiehChief Financial Officer & Member of Management Board0N/A

Description

NanoRepro AG develops, manufactures, and distributes rapid diagnostic tests and food supplements for home and professional use in Germany and internationally. It provides products in the areas of family planning and disease detection, as well as food intolerances, allergies, and infectious diseases. The company offers rapid diagnostic tests, including allergy, family planning, and preventive healthcare line products; point of care testing products for hospitals and medical practices for detection of HIV, human cardiac Troponin I, D-dimer, streptococci antigen, influenza type A and B antigens, and microalbumin; and immunochromatographic lateral flow tests for the diagnostic detection of biomarkers, as well as rapid SARS-CoV-2 antibody test and corona antigen rapid test. It also provides food supplements for men and women through online shops, as well as through pharmacies. The company is headquartered in Marburg, Germany.